Robert Schlegel

Georgetown University Medical Center

Papers

1

Total Citations

31

H-Index

1

About

Robert Schlegel is a prominent virologist and cancer researcher whose work has fundamentally advanced the understanding of human papillomavirus (HPV) oncogenesis. His key research areas include HPV-mediated cellular immortalization, viral oncoproteins E6 and E7, and the molecular mechanisms driving cervical cancer development. Schlegel’s major contributions center on elucidating how HPV proteins disrupt normal cell cycle regulation, particularly through interactions with tumor suppressors like p53 and Rb. His landmark study on insulin-like growth factor-binding protein 3 (IGFBP-3) expression during HPV type 16 E6/E7-induced immortalization of cervical keratinocytes demonstrated a critical link between viral oncoproteins and growth factor signaling pathways. This work, cited 31 times, provided foundational insights into how HPV manipulates cellular senescence and proliferation. Beyond this, Schlegel’s research has been instrumental in characterizing the role of viral proteins in chromatin remodeling and immune evasion. His findings have direct implications for HPV vaccine development and targeted therapies against cervical and other HPV-associated cancers. Schlegel’s sustained contributions have made him a respected figure in tumor virology, with his studies continuing to inform both basic science and clinical applications in cancer prevention.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Insulin-Like Growth Factor-Binding Protein 3 Expression Increases during Immortalization of Cervical Keratinocytes by Human Papillomavirus Type 16 E6 and E7 Proteins
31 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Georgetown University Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago